This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thiéry, G. Articles by Schlemmer, B. Search for Related Content PubMed PubMed Citation Articles by Thiéry, G. Articles by Schlemmer, B.

Outcome of Cancer Patients Considered for Intensive Care Unit Admission: A Hospital-Wide Prospective Study

From the Saint Louis Teaching Hospital; Paris 7 University; Assistance Publique–Hôpitaux de Paris, Paris, France

Address reprint requests to Guillaume Thiéry, Medical Intensive Care Unit, Saint Louis Teaching Hospital, 1 rue Claude Vellefaux, 75010 Paris, France; e-mail: guillaume.thiery{at}sls.ap-hop-paris.fr

PURPOSE: To evaluate the outcome of cancer patients considered for admission to the intensive care unit (ICU).

PATIENTS AND METHODS: Prospective, one-year hospital-wide study of all cancer and hematology patients, including bone marrow transplantation patients, for whom admission to the ICU was requested.

RESULTS: Of the 206 patients considered for ICU admission, 105 patients (51%) were admitted. Of the 101 patients who were not admitted, 54 patients (26.2%) were considered too sick to benefit, and 47 patients (22.8%) were considered to be too well to benefit from the ICU. Of these 47 patients, 13 patients were admitted later. Survival rates after 30 and 180 days were significantly associated with admission status (P < .0001). Remission of the malignancy (odds ratio [OR], 3.37; 95% CI, 1.25 to 9.07) was independently associated with ICU admission, whereas poor chronic health status (OR, 0.38; 95% CI, 0.16 to 0.74) and solid tumor (OR, 0.43; 95% CI, 0.24 to 0.78) were associated with ICU refusal. In admitted patients, 30-day and 6-month survival rates were 54.3% and 32.4%, respectively. Of the patients considered too sick to benefit from ICU admission, 26% were alive on day 30 and 16.7% on day 180. Among patients considered too well to benefit, the 30-day survival rate was a worrisome 78.7%. Calibration of the Mortality Probability Model (the only score available at triage) was of limited value for predicting 30-day survival (area under the curve, 0.62).

CONCLUSION: Both the excess mortality in too-well patients later admitted to the ICU and the relatively good survival in too-sick patients suggest the need for a broader admission policy.

Supported by grants from the French Society for Critical Care Medicine and the Assistance Publique–Hôpitaux de Paris.

Presented in part at the Congress of the French Society of Intensive Care (SRLF), January 2004.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

This article has been cited by other articles:

				V. Mendoza, A. Lee, and P. E. Marik The Hospital-Survival and Prognostic Factors of Patients With Solid Tumors Admitted to an ICU American Journal of Hospice and Palliative Medicine, June 1, 2008; 25(3): 240 - 243. [Abstract] [PDF]

				A. K. Adam and A. O. Soubani Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit Eur. Respir. J., January 1, 2008; 31(1): 47 - 53. [Abstract] [Full Text] [PDF]

				M. Soares, M. Darmon, J. I. F. Salluh, C. G. Ferreira, G. Thiery, B. Schlemmer, N. Spector, and E. Azoulay Prognosis of Lung Cancer Patients With Life-Threatening Complications Chest, March 1, 2007; 131(3): 840 - 846. [Abstract] [Full Text] [PDF]

				M. Soares, J. I.F. Salluh, M. S. Carvalho, M. Darmon, J. R. Rocco, and N. Spector Prognosis of Critically Ill Patients With Cancer and Acute Renal Dysfunction J. Clin. Oncol., August 20, 2006; 24(24): 4003 - 4010. [Abstract] [Full Text] [PDF]

				F. Pene, C. Aubron, E. Azoulay, F. Blot, G. Thiery, B. Raynard, B. Schlemmer, G. Nitenberg, A. Buzyn, P. Arnaud, et al. Outcome of Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients: A Reappraisal of Indications for Organ Failure Supports J. Clin. Oncol., February 1, 2006; 24(4): 643 - 649. [Abstract] [Full Text] [PDF]